Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals
Roswell Park Cancer Institute
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)
Office of Rare Diseases (ORD)